These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 129288)
1. [Detection of antibodies against Coxsackie A, B and Echo viruses in human sera by the method of two-dimensional immunodiffusion on agar gel. I. Precipitating antibodies against Coxackie viruses group B]. Dupková E Cesk Epidemiol Mikrobiol Imunol; 1975 Sep; 24(5):270-4. PubMed ID: 129288 [No Abstract] [Full Text] [Related]
2. [Inactivated combined Coxsackie A-9 and B-1 as well as Echo-6 vaccine. II. Immunogenicity of the combined vaccine]. Biernacki M; Jabloński L Med Dosw Mikrobiol; 1974; 26(4):347-50. PubMed ID: 4475337 [No Abstract] [Full Text] [Related]
3. [Quick antiserum preparation for the virus CF-test. Immunisation of rats with enteroviruses (ECHO and Coxsackie) and respiratory syncytial (RS) viruses]. Adam D Zentralbl Bakteriol Orig; 1970 May; 213(4):470-8. PubMed ID: 5455470 [No Abstract] [Full Text] [Related]
4. [Sensitive virologic evaluation in suspected meningitis: study of a radioimmunotest for the detection of IgM antibodies against ECHO 9 and ECHO 11 viruses]. Burkhardt F; Reigel F; Schilt U Schweiz Med Wochenschr; 1983 Jun; 113(25):902-9. PubMed ID: 6612271 [TBL] [Abstract][Full Text] [Related]
5. [Antibodies against enterovirus (ECHO virus 7, 11, 12 and coxsackie virus B 3) of the inhabitants of Okinawa and South-Western islands in Pacific ocean]. Higashi T Kumamoto Igakkai Zasshi; 1971 May; 45(5):588-624. PubMed ID: 5171705 [No Abstract] [Full Text] [Related]
6. Enterovirus immunodiffusion reactions: a comparison of results obtained in agarose and agar using two different microdiffusion systems. Styk B; Schmidt NJ J Immunol; 1968 Jun; 100(6):1223-9. PubMed ID: 4972185 [No Abstract] [Full Text] [Related]
7. Distribution of antibodies against Coxsackie B viruses, arboviruses and Toxoplasma gondii among patients with endomyocardial fibrosis (EMF) compared with normal subjects from EMF endemic and non-endemic zones of Nigeria. Ijaola O; Falase AO Afr J Med Med Sci; 1990 Jun; 19(2):93-103. PubMed ID: 2165348 [TBL] [Abstract][Full Text] [Related]
8. [Age distribution of neutralizing antibodies against Coxsackie and ECHO viruses among inhabitants of the Morioka area]. Kawana R; Kaneko M Igaku To Seibutsugaku; 1965 Dec; 71(6):373-7. PubMed ID: 5895001 [No Abstract] [Full Text] [Related]
9. Acquisition of antibodies to various Coxsackie and Echo viruses and hepatitis A virus in agricultural communal settlements in Israel. Morag A; Margalith M; Shuval HI; Fattal B J Med Virol; 1984; 14(1):39-47. PubMed ID: 6747611 [TBL] [Abstract][Full Text] [Related]
10. [Immunity response of 3 animal species (guinea pigs, hamsters, mice) to various Coxsackie viruses of group A. II. Study of antibodies detected by gel immunodiffusion: comparison with complement fixing antibodies]. Bringuier JP; Gaudin OG; Brigaud M; Terraillon J; Sohier R Ann Inst Pasteur (Paris); 1971 Oct; 121(4):551-61. PubMed ID: 5004043 [No Abstract] [Full Text] [Related]
11. Indirect enzyme-linked immunosorbent assay (ELISA) for detection of IgG antibodies against Coxsackie B viruses. Hannington G; Booth JC; Wiblin CN; Stern H J Med Microbiol; 1983 Nov; 16(4):459-65. PubMed ID: 6315943 [TBL] [Abstract][Full Text] [Related]
12. Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides. Haarmann CM; Schwimmbeck PL; Mertens T; Schultheiss HP; Strauer BE Virology; 1994 May; 200(2):381-9. PubMed ID: 7513917 [TBL] [Abstract][Full Text] [Related]
13. Counter-electrophoresis as a possible method for typing ECHO and Coxsackie B viruses. MacWilliam KM; Cook KM J Hyg (Lond); 1975 Apr; 74(2):239-44. PubMed ID: 1054727 [TBL] [Abstract][Full Text] [Related]
14. [Changes in antibody titers against an enterovirus (ECHO 22) in North Bavaria in relation to mortality from heart disease 1977 to 1981]. Moldenhauer D Zentralbl Bakteriol Mikrobiol Hyg B; 1984 Jan; 178(5-6):502-9. PubMed ID: 6326426 [TBL] [Abstract][Full Text] [Related]
15. [Does virus diagnosis open new ways for the classification and treatment of sudden deafness, unilateral vestibular loss and idiopathic facial paralysis?]. Leitner C HNO; 1986 Sep; 34(9):376-8. PubMed ID: 3771296 [TBL] [Abstract][Full Text] [Related]
16. [The value of the Coxsackie B virus complement fixation test (author's transl)]. Hofmann H Wien Klin Wochenschr; 1975 Dec; 87(24):819-22. PubMed ID: 1226771 [TBL] [Abstract][Full Text] [Related]
17. Analysis of antibody responses against coxsackie virus B4 protein 2C and the diabetes autoantigen GAD(65). Vreugdenhil GR; Batstra MR; Aanstoot HJ; Melchers WJ; Galama JM J Med Virol; 1999 Oct; 59(2):256-61. PubMed ID: 10459165 [TBL] [Abstract][Full Text] [Related]
18. [Persistence of latex-agglutination inhibiting and neutralizing antibodies against enterovirus in the healthy population (author's transl)]. Schmidt WA; Brade H; Klein M; Krämer U Dtsch Med Wochenschr; 1975 Aug; 100(33):1663-6. PubMed ID: 169112 [TBL] [Abstract][Full Text] [Related]
19. [Antibody levels against coxsackie B viruses in patients with type 1 diabetes mellitus]. Emekdaş G; Rota S; Kuştimur S; Kocabeyoğlu O Mikrobiyol Bul; 1992 Apr; 26(2):116-20. PubMed ID: 1316989 [TBL] [Abstract][Full Text] [Related]
20. [Pathophysiological background of transient hyperphosphatasemia]. Suzuki M; Okazaki T; Asahara M; Kadohno N; Kanno T Rinsho Byori; 1998 Jan; 46(1):88-90. PubMed ID: 9492545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]